Cervical Cancer Detection Startup Biop Gets FDA Approval

Israel-based cancer detection startup Biop Medical Ltd. has received approval from the U.S. Food and Drug Administration (FDA) for its first product, the company announced Sunday. Founded in 2013 and based in Ramat Gan, a town just east of Tel Aviv, Biop developed a device that maps the cervix and identifies cancerous and precancerous cells in epithelial tissues. The company has raised $4.45 million to date, from investors including South Africa-based medical equipment company Avacare Health Group and the Israel Innovation Authority, a government tech investment arm.

Biop's team. Photo: Biop